The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
Vidailhet
M
M
Service de Neurologie, Hôpital Saint-Antoine, and U 289, Hôpital de la SalPêtrière, Paris, France.
Bonnet
A M
AM
Marconi
R
R
Durif
F
F
Agid
Y
Y
D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis / Q000209:etiology*; D000882:Haplorhini; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy*; D012720:Severity of Illness Index
D000978:Antiparkinson Agents; D007980:Levodopa